Key Pharmacy and Compounding Center product recalled over sterility concerns
- Recall date
- April 18, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Key Pharmacy and Compounding Center recalls CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ, Injection, 25mg/mL, Rx only, 20mL Glass /Multiple Dose vial, Prepared by Key…
- Recall number
- D-0713-2017
- FDA classification
- Class II
- Brand / firm
- Key Pharmacy and Compounding Center
- Sold / distributed
- Distributed nationwide in U.S.A., Australia and Canada.
Why it was recalled
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ, Injection, 25mg/mL, Rx only, 20mL Glass /Multiple Dose vial, Prepared by Key Compounding Pharmacy
Get recall alerts
Free email alert whenever Key Pharmacy and Compounding Center has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Key Pharmacy and Compounding Center